We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.00 | -2.15% | 45.50 | 45.00 | 46.00 | 46.50 | 44.75 | 46.50 | 4,092,357 | 16:04:09 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.29 | 129.04M |
From May 2019 to May 2024
TIDMAVCT
RNS Number : 7107M
Avacta Group PLC
11 May 2015
Press Release 11 May 2015
Avacta Group plc
("Avacta" or the "Group")
Issue of Equity
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, today announces that 250,000 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options by a former employee.
Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 14 May 2015.
The total number of Ordinary Shares in issue following the above issue will be 4,979,399,550 each with voting rights. No Ordinary Shares are held in Treasury.
The above figure of 4,979,399,550 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.
- Ends -
Enquiries:
Hot Features
Premium
Avacta Group plc Tel: +44 (0) 844
414 0452
Alastair Smith, Chief Executive www.avacta.com
Officer
Tim Sykes, Chief Financial
Officer
Numis Securities Limited Tel: +44 (0) 207
260 1000
Michael Meade / Freddie Barnfield www.numiscorp.com
- Nominated
Adviser
James Black - Corporate Broking
Walbrook PR Limited Tel: +44 (0) 20 7933 8780
or avacta@walbrookpr.com
Paul McManus Mob: +44 (0)7890 541 893
Lianne Cawthorne Mob: +44 (0)7584 391 303
About Avacta Group plc - www.avacta.com
Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through two divisions:
Avacta Animal Veterinary diagnostics reference
Health laboratory and diagnostic kit
www.avactaanimalhealth.com provider.
---------------------------- ---------------------------------------
Avacta Life Sciences Novel non-antibody affinity
www.avactalifesciences.com reagents called Affimers, with
a wide range of Life Science
applications in diagnostics,
drug and biomarker discover
and biotech research and development.
---------------------------- ---------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEUKOORVKAVRAR
1 Year Avacta Chart |
1 Month Avacta Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
